Immunoassay

Kalorama Information’s latest report, Autoimmune Immunoassay Market Opportunities, 2021-2026, delves into the expansive and evolving landscape of diagnostic tests for autoimmune diseases. As the market for autoimmune diagnostics continues to grow, substantial opportunities for innovation and advancement emerge. This report provides a comprehensive analysis of current and future market prospects, highlighting the potential for revenue…

Description:

Kalorama Information’s latest edition of our comprehensive in vitro diagnostic market report is now available. For the fourteenth time in two decades, our analysts have meticulously reassessed and updated the in vitro diagnostic market data. The COVID-19 pandemic underscored the critical importance of testing in an unprecedented way. In 2021, COVID-19 testing has become…

Latin America (LATAM) presents significant expansion opportunities for in vitro diagnostic (IVD) manufacturers. Kalorama Information’s latest report focuses on the market for reagents and instruments across key LATAM countries, including Argentina, Brazil, Chile, Colombia, Mexico, Peru, and Venezuela. Additionally, the report covers Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras,…

Kalorama Information’s United States Market for In Vitro Diagnostic (IVD) Tests, 3rd Edition provides a comprehensive and insightful analysis of the IVD market in the U.S. This market, the largest in the world, is undergoing significant changes influenced by various factors, including the profound impact of COVID-19.

Market Dynamics:

Explore the current state and…

For further details and to purchase directly, please contact us.

Diagnostic test products have never been more critical. Kalorama Information’s report, 2021 IVD Market Update and COVID-19 Impact, provides an updated analysis of the in vitro diagnostics (IVD) market, reflecting the latest information from our analysts. This comprehensive report includes market sizing for various IVD categories and examines the major trends and impacts of COVID-19…

In vitro diagnostic (IVD) test volumes are crucial for assessing market opportunities for new entrants with diagnostic products and beneficial for existing product marketers. Kalorama’s In Vitro Diagnostic (IVD) Procedure Volumes, 2020-2025 delivers comprehensive market analysis, saving time with detailed calculations and estimates for the current and future number of diagnostic tests across multiple categories.…

The Worldwide Market for Laboratory-Developed Tests (LDTs), 2nd Edition provides a comprehensive analysis of the global sequencing market. This report covers market trends, challenges, strategies, and detailed profiles of key companies and products. It includes precise market share estimates and revenue growth forecasts, offering insights into the competitive landscape, including major deals and product developments.…

Urgent care centers (UCCs) are a vital and growing segment of the U.S. healthcare system, with around 10,000 locations nationwide. They offer walk-in care, a broad range of services, extended hours, and minimal wait times. Kalorama Information’s report, The U.S. Market for Urgent Care Centers (Including COVID-19, POC Tests, Vaccines and Other Sales), 2^nd Edition,…

Description:

The past few years have seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market, and many more are in development. In recent years, diagnostics companies, in collaboration with AI companies, have begun implementing increasingly sophisticated machine learning…

CAR-T Cell Therapy Market Review provides an insightful examination of CAR-T therapy, a revolutionary form of immunotherapy harnessing the body’s T cells to target and eradicate cancer cells. This report delves into the technology behind CAR-T, its application in treating diseases like acute lymphoblastic leukemia, DLBCL B-cell lymphomas, and multiple myeloma.

Key Objectives and Questions…

HbA1c testing has become a critical component in the detection and monitoring of diabetes, leading to a highly competitive and rapidly growing market within the in vitro diagnostics (IVD) industry. With increasing global expenditures on both professional and self-testing HbA1c assays, the market is flourishing. Over a dozen companies are actively producing analyzers, reagents, workstations,…